Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 1285
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT06923397 | Interrupting Sedentary Time to Improve Cardiometabolic Health and Toxicity in Patients With Lymphoma Receiving Chemotherapy: The iSTAND Trial | ||
| NCT00165555 | Pleurectomy/Decortication Followed by Intrathoracic/Intraperitoneal Heated Cisplatin for Malignant Pleural Mesothelioma | ||
| NCT04724018 | Sacituzumab Govitecan Plus EV in Metastatic UC | ||
| NCT00554515 | The High-Dose Aldesleukin (IL-2) "Select" Trial for Patients With Metastatic Renal Cell Carcinoma | ||
| NCT01878708 | A Pilot Study of Oncaspar® + Dexamethasone in Patients With Relapsed or Refractory T-Cell Lymphoma | ||
| NCT06246084 | INTENT Pilot Study - Enhancing Adherence Intentions to Endocrine Therapy | ||
| NCT01522768 | Afatinib and Paclitaxel in Patients With Advanced HER2-Positive Trastuzumab-Refractory Advanced Esophagogastric Cancer | ||
| NCT05010629 | 9-ING-41 Plus Carboplatin in Salivary Gland Carcinoma | ||
| NCT02926729 | Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy | ||
| NCT01965353 | A Phase I Study Of Panobinostat/Lenalidomide/Bortezomib/Dex for Relapsed And Relapsed/Refractory Multiple Myeloma | ||
| NCT02355340 | Bone Mineral Density Status in Pediatric and Adolescent Survivors of Childhood Cancer With History of Bone Fracture | ||
| NCT04569747 | A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer | ||
| NCT02268175 | Enzalutamide/Leuprolide +/- Abiraterone/Pred in Prostate | ||
| NCT00095901 | Capecitabine For Nasopharyngeal Cancer | ||
| NCT02203825 | Safety Study of Chimeric Antigen Receptor Modified T-cells Targeting NKG2D-Ligands | ||
| NCT01972516 | Tivozanib As Maintenance Therapy In GYN | ||
| NCT07303816 | Statins to Prevent Cancer Associated Blood Clots | ||
| NCT02653755 | The PRECISION Trial (Profiling Early Breast Cancer for Radiotherapy Omission): A Phase II Study of Breast-Conserving Surgery Without Adjuvant Radiotherapy for Favorable-Risk Breast Cancer | ||
| NCT06153797 | A Positive Psychology Based Intervention (PATH-C) for Caregivers of HSCT Survivors | ||
| NCT01661868 | Olaparib for Patients With Recurrent BRCA Deficient Ovarian Cancer | ||
| NCT06488378 | Phase Ib Study of Axatilimab in Combination With Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer | ||
| NCT04024878 | NeoVax With Nivolumab in Patients With Ovarian Cancer | ||
| NCT03520790 | Paricalcitol Plus Gemcitabine and Nab-paclitaxel in Metastatic Pancreatic Cancer | ||
| NCT00590902 | Ph II OSI-774 (Erlotinib,Tarceva) In Advanced Bronchioloalveolar Cell Lung Cancer | ||
| NCT00083031 | Metronomic Low-Dose Cyclophosphamide and Methotrexate With or Without Bevacizumab in Treating Women With Metastatic Breast Cancer | ||
| NCT00148707 | Study of Xyotax (CT-2103) in Patients With Metastatic Breast Cancer | ||
| NCT03316573 | Pembrolizumab in Neoplasms or Lymphomas | ||
| NCT00441142 | Zactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain Tumors | ||
| NCT00090857 | Letrozole in Preventing Breast Cancer in Postmenopausal Women | ||
| NCT00809367 | Collection and Banking of Leukemia Cells MDS/AML | ||
| NCT00321646 | Neoadjuvant Bevacizumab Plus Docetaxel in High Risk Patients With Prostate Cancer Undergoing Radical Prostatectomy | ||
| NCT04273139 | Ibrutinib + Venetoclax in Untreated WM | ||
| NCT06803875 | Study of hALK.CAR T Cells for Patients With Relapsed/Refractory High-risk Neuroblastoma | ||
| NCT03716739 | Improving Quality of Life of Prostate Cancer Survivors With Androgen Deficiency | ||
| NCT00842257 | Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal Cancer | ||
| NCT05706766 | Prehabilitation Exercise Training in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation | ||
| NCT06034431 | Increasing Access to Definitive Treatment for Prostate Cancer | ||
| NCT04497142 | Effect of Perampanel on Peritumoral Hyperexcitability in HGG | ||
| NCT04661852 | Cabozantinib With Topotecan-Cyclophosphamide | ||
| NCT01002248 | Assessment of Efficacy and Safety of Perifosine, Bortezomib and Dexamethasone in Multiple Myeloma Patients | ||
| NCT00142116 | Thalidomide and Rituximab in Waldenstrom's Macroglobulinemia | ||
| NCT01623349 | Phase I Study of the Oral PI3kinase Inhibitor BKM120 or BYL719 and the Oral PARP Inhibitor Olaparib in Patients With Recurrent Triple Negative Breast Cancer or High Grade Serous Ovarian Cancer | ||
| NCT00768144 | Sunitinib in Recurrent and Refractory Ovarian, Fallopian Tube and Peritoneal Carcinoma | ||
| NCT01066663 | Pyrimethamine for the Treatment of Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | ||
| NCT02641236 | Gut Decontamination In Pediatric Allogeneic Hematopoietic | ||
| NCT02390414 | The Myelodysplasia Transplantation-Associated Outcomes (MDS-TAO) Study | ||
| NCT00181584 | Zoledronic Acid to Prevent Bone Loss During Androgen Deprivation Therapy for Prostate Cancer | ||
| NCT00147212 | ET 743 (Yondelis) in Men With Advanced Prostate Cancer | ||
| NCT01378598 | Enhancing Adherence and Knowledge of Erlotinib in Patients Wtih Non-Small Cell Lung Cancer | ||
| NCT03936465 | Study of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitors BMS-986158 and BMS-986378 in Pediatric Cancer |
